Diagnamed Holdings Corp.
DMED
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 41.22% | -45.17% | -41.90% | -38.98% | -7.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.59% | -33.72% | -37.01% | -43.18% | -38.37% |
| Operating Income | -31.59% | 33.72% | 37.01% | 43.18% | 38.37% |
| Income Before Tax | -80.26% | -29.77% | 25.39% | 61.16% | 52.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -80.26% | -29.77% | 25.39% | 61.16% | 52.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -80.26% | -29.77% | 25.39% | 61.16% | 52.73% |
| EBIT | -31.59% | 33.72% | 37.01% | 43.18% | 38.37% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -62.50% | -29.63% | 25.30% | 61.98% | 54.84% |
| Normalized Basic EPS | -21.28% | 8.89% | 30.51% | 43.84% | 38.96% |
| EPS Diluted | -62.50% | -29.63% | 25.30% | 61.98% | 54.84% |
| Normalized Diluted EPS | -21.28% | 8.89% | 30.51% | 43.84% | 38.96% |
| Average Basic Shares Outstanding | 7.19% | 1.40% | 1.37% | 2.38% | 3.66% |
| Average Diluted Shares Outstanding | 7.19% | 1.40% | 1.37% | 2.38% | 3.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |